Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Jay Shepard


  • Director at Esperion Therapeutics Inc. (ESPR), 2020-05-29
  • Director at Inovio Pharmaceuticals Inc. (INO), 2020-05-15
  • Other at Aravive Inc. (ARAV), 2020-04-09
  • Director at Marinus Pharmaceuticals Inc (MRNS), 2017-01-19
  • Director at Durect Corp (DRRX), 2016-06-23
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ARAV $6.82 4,004 Officer, Director 72,754 2019-10-07 Filing
ARAV $6.11 1,192 Officer, Director 76,758 2019-05-10 Filing
ARAV $4.14 990 Officer, Director 81,950 2019-02-01 Filing
ARAV $4.14 969 Officer, Director 82,940 2019-02-01 Filing
ARAV $4.14 204 Officer, Director 83,909 2019-02-01 Filing